1. Home
  2. MGIH vs HCWB Comparison

MGIH vs HCWB Comparison

Compare MGIH & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Millennium Group International Holdings Limited

MGIH

Millennium Group International Holdings Limited

HOLD

Current Price

$1.58

Market Cap

18.2M

ML Signal

HOLD

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.09

Market Cap

14.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGIH
HCWB
Founded
1978
2018
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
14.8M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
MGIH
HCWB
Price
$1.58
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
39.8K
1.4M
Earning Date
10-28-2025
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.37
Revenue
N/A
$4,099,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.11
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.25
52 Week High
$4.84
$7.35

Technical Indicators

Market Signals
Indicator
MGIH
HCWB
Relative Strength Index (RSI) 55.16 44.00
Support Level $1.40 $1.03
Resistance Level $1.82 $1.17
Average True Range (ATR) 0.14 0.17
MACD 0.00 -0.09
Stochastic Oscillator 49.99 13.32

Price Performance

Historical Comparison
MGIH
HCWB

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd supplies paper-based packaging solutions, including inner packaging boxes produced with offset or flexo printing and outer corrugated boxes used for transportation, storage, pallets, and point-of-purchase displays. The company manufactures corrugated products of different sizes, shapes, thicknesses, and strengths according to customer specifications. It also operates a supply chain management business in Vietnam to service international clients who source their packaging needs from Vietnam and other ASEAN countries. The corrugated paper is durable, versatile, economical, and lightweight.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: